Need for Efficient Delivery Mechanisms drives Global Drug Delivery Market Growth
According to Inkwood Research, the Global Drug Delivery
Market is projected to register a CAGR of 6.84% in
terms of revenue during the forecasting years of 2022-2030.
“Browse 83 Market Data Tables and 120 Figures
spread over 366 Pages, along with an in-depth TOC on the Global Drug Delivery
Market Forecast 2022-2030.”
VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/drug-delivery-market/#table-of-contents
Drug delivery is a technology that delivers
the drug to the desired body site for drug release and absorption. It is a
formulation that facilitates the introduction of a therapeutic substance in the
body, improving its efficacy by regulating the place, time, and rate of the
drug release in the body. For instance, drug delivery can tremendously affect
retinal disease treatment.
REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/drug-delivery-market/#request-free-sample
Rising
Demand for Effective Drug Delivery Mechanisms propels Market Growth
The increasing demand for effective
delivery mechanisms propels the demand for drug delivery technology. This is
because these offer several advantages over conventional delivery systems.
These include increased duration and efficacy of drug activity, enhanced
targeting of a specific site, decreased dosing frequency, and more convenient
routes of administration to minimize unwanted side effects.
Also, drug delivery technologies aid drug
manufacturers in differentiating new therapeutics from existing products. For
instance, scientists in the US developed an oral method for administrating
insulin in 2016. The method was an alternative for diabetes patients and less
painful than the conventional one requiring them to inject themselves to manage
blood sugar levels. Moreover, advanced drug delivery technologies help surpass
conventional barriers like poor solubility, enzyme degradation, poor
solubility, etc., involved in conventional oral drug delivery mechanisms.
Highest
Revenue-Generating Route of Administration: Oral Drug Delivery (ODD)
ODD (oral drug delivery) is an increasingly
preferred route of drug administration since it offers ease in the
manufacturing process, flexibility in dosage design form, cost-effectiveness,
fewer sterility constraints, non-invasiveness, and high patient compliance.
Designing innovative drugs and ODD is an emerging field.
Also, manufacturers are developing oral
drugs for different infectious diseases and chronic diseases. For instance,
oral drugs like Sulfonylureas and Metformin can help achieve diabetes patients
required blood sugar levels. At the same time, ODD problems include poor drug
administration bioavailability due to solubility, permeability, and
dissolution.
Largest
Revenue-Generating Region: North America
In North America, the growing prevalence of
health-related disorders and diseases propels the demand for advanced
healthcare services and technologically advanced equipment and treatment
methods. Also, the requirement for competent and qualified medical professionals
to operate such equipment offers high employment opportunities. The other
factors contributing to the market growth are the increased healthcare
expenditure, prevalence of chronic disease, and the aging population.
The increasing number of dealers and distributors
is projected to increase the competitive rivalry. Also, market players are
gaining market penetration through geographic expansion in developing
countries.
Request for Customization: https://inkwoodresearch.com/request-for-custom-report/
Contact Us
https://www.inkwoodresearch.com
1-(857) 293-0150
Related
Reports:
GLOBAL
PULMONARY DRUG DELIVERY MARKET
GLOBAL
BIOMATERIALS MARKET
GLOBAL
INJECTABLE DRUG DELIVERY MARKET
GLOBAL DRUG DISCOVERY
MARKET

Comments
Post a Comment